Home > Annual Financials > AARTI PHARMALABS

AARTI PHARMALABS Financial Statement Analysis
[BOM: 543748|NSE : AARTIPHARM]

The Revenues of AARTI PHARMALABS have decreased by -4.76% YoY .
The Earnings Per Share (EPS) of AARTI PHARMALABS has increased by 25.62 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

AARTI PHARMALABS Last 5 Annual Financial Results
[BOM: 543748|NSE : AARTIPHARM]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹1,853 Cr₹1,945 Cr₹1,200 Cr₹0.00 Cr₹0.00 Cr
Expenses ₹1,467 Cr₹1,603 Cr₹995 Cr₹0.01 Cr₹0.01 Cr
Operating Profit (Excl OI) ₹386 Cr₹342 Cr₹205 Cr₹-0.01 Cr₹-0.01 Cr
Other Income ₹4.90 Cr₹2.32 Cr₹4.19 Cr₹0.00 Cr₹0.00 Cr
Interest ₹17 Cr₹21 Cr₹12 Cr₹0.00 Cr₹0.00 Cr
Depreciation ₹73 Cr₹63 Cr₹42 Cr₹0.00 Cr₹0.00 Cr
Profit Before Tax ₹300 Cr₹261 Cr₹155 Cr₹-0.01 Cr₹-0.01 Cr
Profit After Tax ₹217 Cr₹193 Cr₹122 Cr₹-0.01 Cr₹-0.01 Cr
Consolidated Net Profit ₹217 Cr₹193 Cr₹122 Cr₹-0.01 Cr₹-0.01 Cr
Earnings Per Share (Rs)₹30.06₹23.93₹21.35₹4,890.04₹-0.18
PAT Margin (%)12.8811.719.9510.190.00
ROE(%)14.5513.0813.3518.23-2.02
ROCE(%)17.5916.7516.1119.40-1.87
Total Debt/Equity(x)0.200.150.140.250.08

Key Financials

Market Cap : ₹ 7,541.1 Cr
Revenue (TTM) : ₹ 1,945.8 Cr
Net Profit(TTM) : ₹ 268.3 Cr
EPS (TTM) : ₹ 29.6
P/E (TTM) : 28.1

Industry Peers & Returns1W1M1Y
AARTI PHARMALABS 1% -9.4% 34.5%
SUN PHARMACEUTICAL INDUSTRIES 0.6% 3.6% -12.5%
DIVIS LABORATORIES 1% 9.4% 8%
CIPLA 0.9% 1.2% -0.2%
TORRENT PHARMACEUTICALS 1.7% 1% 1%
DR REDDYS LABORATORIES -0.5% -4.2% -6.3%
MANKIND PHARMA 1.5% -3.5% -10.6%
ZYDUS LIFESCIENCES -0.6% -4.6% -7%
LUPIN -1.6% -4.5% -13.3%


AARTI PHARMALABS Revenues
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

-4.76 %

5 Yr CAGR

0 %

Years Revenues % Change
Mar2025 ₹1,853 Cr
-4.76
Mar2024 ₹1,945 Cr
62.11
Mar2023 ₹1,200 Cr
0
Mar2022 ₹0.00 Cr
0
Mar2021 ₹0.00 Cr -


AARTI PHARMALABS Operating Profit
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

12.86 %

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2025 ₹386 Cr
12.86
Mar2024 ₹342 Cr
66.64
Mar2023 ₹205 Cr
Positive
Mar2022 ₹-0.01 Cr
Negative
Mar2021 ₹-0.01 Cr -

Operating Margins
Y-o-Y

18.54 %

5 Yr CAGR

0

Years Operating Margin% % Change
Mar2025 20.84%
18.54
Mar2024 17.58%
2.75
Mar2023 17.11%
0
Mar2022 0%
0
Mar2021 0% -

AARTI PHARMALABS Profit After Tax
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

12.10 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2025 ₹217 Cr
12.10
Mar2024 ₹193 Cr
58.28
Mar2023 ₹122 Cr
Positive
Mar2022 ₹-0.01 Cr
Negative
Mar2021 ₹-0.01 Cr -

PAT Margins
Y-o-Y

9.99 %

5 Yr CAGR

0

Years PAT Margin(%) % Change
Mar2025 12.88 %
9.99
Mar2024 11.71 %
17.69
Mar2023 9.95 %
-2.36
Mar2022 10.19 %
0
Mar2021 0 % -

AARTI PHARMALABS Earnings Per Share (EPS)
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

25.62 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹30
25.62
Mar2024 ₹24
12.08
Mar2023 ₹21
-99.56
Mar2022 ₹4,890
Positive
Mar2021 ₹-0.18 -

AARTI PHARMALABS Return on Capital Employed (ROCE)
[BOM: 543748|NSE : AARTIPHARM]

Y-o-Y

5.01 %

5 Yr CAGR

Positive

Years ROCE % Change
Mar2025 17.59%
5.01
Mar2024 16.75%
3.97
Mar2023 16.11%
-16.96
Mar2022 19.4%
Positive
Mar2021 -1.87% -

AARTI PHARMALABS Share Price vs Sensex

Current Share Price : ₹832.4
Current MarketCap: ₹ 7,541.1 Cr
Updated EOD on :Oct 17,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

1%

-9.4%

34.5%

SENSEX

1.8%

1.9%

2.4%

AARTI PHARMALABS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 0.5% 0.3% 0.6%
BSE SMALLCAP -0.6% -2.3% -6.3%
NSE Indices1W1M1Y
NIFTY TOTAL MARKET 1.1% 0.8% -0.9%
NIFTY MICROCAP 250 -0.7% -2.9% -8.5%

You may also like the below Video Courses


FAQ about AARTI PHARMALABS Financials


How the annual revenues of AARTI PHARMALABS have changed ?

The Revenues of AARTI PHARMALABS have decreased by -4.76% YoY .

How the Earnings per Share (EPS) of AARTI PHARMALABS have changed?

The Earnings Per Share (EPS) of AARTI PHARMALABS has increased by 25.62 % YoY .